Clinical trial Recruiting at 1 site Interventional Ages 0 Days to 19

Near-infrared imaging to help place peripheral IVs in children

Official title: The Effect of Near-infrared Spectroscopy on the Success of Peripheral Venous Access: a Pilot Randomized Controlled Study

Run by Brno University Hospital · NCT07279701 · Data updated 2026-11-12

This study will see if near-infrared imaging helps doctors place peripheral IVs successfully on the first try for children who need IV access.

Quick facts

Study typeInterventional
Ages0 Days to 19 Years
SexAll
Enrollment200 (estimated)
SponsorBrno University Hospital
Academic / other
Locations1 site (Brno, South Moravian)
StatusRecruiting
StartedDecember 15, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedFebruary 27, 2026
Trial IDNCT07279701 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children admitted to the pediatric anesthesia or intensive care sections at University Hospital Brno who require peripheral IV insertion and whose legal guardian consents to participation.

Probably not a fit

Patients not requiring peripheral IVs, those whose veins are too deep for near-infrared visualization, or cases where the device is unavailable are unlikely to benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Pediatric patients needing peripheral venous access in the Department of Pediatric Anesthesiology and Resuscitation at University Hospital Brno will have IV placement performed using a near-infrared device (VeinViewer Flex). The trial compares first-attempt success rates and total number of attempts when operators use near-infrared imaging versus standard visual/palpation techniques. Study outcomes include first-attempt success, total attempts to successful cannulation, and any device-related limitations or failures. The work is focused on anesthesia and intensive care settings where small vessel size and limited cooperation increase difficulty of venous access.

Why it matters

Potential benefit: If successful, using near-infrared imaging could increase first-attempt IV success in children and reduce repeat punctures, pain, and procedure-related delays.

How similar studies have gone: Previous studies show near-infrared devices improve vein visualization but have produced mixed results on consistently increasing first-attempt cannulation rates in pediatric populations.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pediatric patients admitted to the inpatient section of the Department of Pediatric Anesthesiology and Resuscitation, Brno University Hospital
* Pediatric patients in the anesthesia section of the Department of Pediatric Anesthesiology and Resuscitation, Brno University Hospital
* Indicated insertion of peripheral venous access
* Consent of the patient/legal representative to the study

Exclusion Criteria:

* Disagreement with the study
* Not indicated insertion of peripheral venous access (according to clinical condition and decision of the attending physician)
* A device for near-infrared imaging of the venous bed is not available

Where it's running

  • University Hospital Brno
    Brno, South Moravian, Czechia
    Recruiting

Study contacts

  • Principal investigator: Petr Štourač, prof, MD, PhD — Brno University Hospital
  • Study coordinator: Hana Harazim, MD, PhD
  • Email: harazim.hana@fnbrno.cz
  • Phone: +420777146704

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.